- Abstract Number: 156
Teaching High Value Musculoskeletal Care Through Online Simulation Cases
- Abstract Number: 36
The Association of Obesity with Pediatric Psoriatic Arthritis
- Abstract Number: 69
The Disease Burden of Systemic Juvenile Idiopathic Arthritis for Patients and Caregivers: An International Health Related Quality of Life Survey and Retrospective Chart Review
- Abstract Number: 117
The Effect of Bisphosphonate Use on Bone Density Measurements in Patients with Muscular Dystrophy
- Abstract Number: 19
The Lymphocyte Repertoire in Juvenile Dermatomyositis
- Abstract Number: 86
The myositis-specific autoantibody and myositis-associated autoantibody phenotypes in Japanese juvenile idiopathic inflammatory myopathies
- Abstract Number: 103
The Performance of a New Risk Assessment Scoring System in Detecting IVIG Resistance in Kawasaki Disease as Compared to the Kobayashi and Egami Scores in a Large Single Centre Canadian Cohort
- Abstract Number: 51
The real-world decisive reasons for drug-escalation and treatment results of synthetic and biological therapy in JIA
- Abstract Number: 34
The SLCO1B1 *14 Allele is Associated with Poor Response to Subcutaneous Methotrexate in Patients with Juvenile Idiopathic Arthritis
- Abstract Number: 43
Tocilizumab Use in Pediatrics With Systemic Juvenile Idiopathic Arthritis: Single Center Data
- Abstract Number: 153
Training pediatric rheumatology fellows intra-articular injection techniques and skills using a cadaver based musculoskeletal curriculum
- Abstract Number: 54
Treatment and 1-year outcomes of an inception cohort of Australian children with JIA
- Abstract Number: 80
Treatment of Blau Syndrome with Biologic Therapy: A Single Center Case Series of Seven Patients Over Two Decades
- Abstract Number: 128
Treatment Response in Polyarticular Juvenile Idiopathic Arthritis is Associated With Transcriptional Changes and Chromatin Reorganization in CD4+ T cells
- Abstract Number: 50
Tumor necrosis factor-α (TNFα) inhibitor-induced psoriasis in juvenile idiopathic arthritis (JIA) patients
2017 Pediatric Rheumatology Symposium
May 17-20, 2017. Houston, Texas.